This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
PICO
Question: Among children <18 months old, does prenatal supplementation with ω-3 fatty acid compared to placebo result in decreased respiratory symptoms?
Question type: Intervention
Study design: Randomized double-blind placebo-controlled
Investigators from multiple institutions assessed whether supplementing pregnant women with ω-3 fatty acids was associated with decreased respiratory symptoms during their infants’ first 18 months of life. This double-blind placebo-controlled trial was carried out in Cuernavaca, Mexico. Investigators recruited pregnant women who agreed to breastfeed exclusively for the first 3 months of the child’s life. Participants were randomly …
Individual Login
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.
Log in through your institution
Purchase access
In this issue
Jump to section
Related Articles
Cited By...
- No citing articles found.